indole-3-carbinol dimer analogs (SRI)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Nameindole-3-carbinol dimer analogs (SRI)
Drug Alias NameI3C oligomer analogs (SRI)indole oligomers (SRI)SR-13654SR-13677
ClassificationSmall molecules
Mechanisms of ActionBaculoviral IAP repeat-containing protein 5 inhibitors
TargetsBaculoviral IAP repeat-containing protein 5
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSri International
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSri International
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A